Αndreas Μelidonis

3.1k total citations · 1 hit paper
42 papers, 903 citations indexed

About

Αndreas Μelidonis is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Αndreas Μelidonis has authored 42 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Cardiology and Cardiovascular Medicine and 11 papers in Epidemiology. Recurrent topics in Αndreas Μelidonis's work include Diabetes Treatment and Management (12 papers), Diabetes Management and Research (11 papers) and Diabetes Management and Education (6 papers). Αndreas Μelidonis is often cited by papers focused on Diabetes Treatment and Management (12 papers), Diabetes Management and Research (11 papers) and Diabetes Management and Education (6 papers). Αndreas Μelidonis collaborates with scholars based in Greece, United States and Japan. Αndreas Μelidonis's co-authors include Athanasia Papazafiropoulou, Eleni Xourgia, Nikolaοs Tentolouris, Anastasios Koutsovasilis, Filippos Triposkiadis, John Skoularigis, Takeshi Kitai, Αndrew Xanthopoulos, Sotirios Patsilinakos and Grigorios Giamouzis and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Atherosclerosis.

In The Last Decade

Αndreas Μelidonis

40 papers receiving 873 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type 2 diabetes and quality of life

2017 395 citations Athanasia Papazafiropoulou, Αndreas Μelidonis et al. World Journal of Diabetes profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Αndreas Μelidonis Greece	13	474	286	120	107	86	42	903
Kristy Iglay United States	17	717 1.5×	276 1.0×	108 0.9×	178 1.7×	111 1.3×	51	1.3k
Xavier Cos Spain	17	739 1.6×	174 0.6×	132 1.1×	170 1.6×	113 1.3×	80	1.1k
Pietro Gallina Italy	16	264 0.6×	247 0.9×	120 1.0×	116 1.1×	142 1.7×	27	987
Aytekin Oğuz Türkiye	16	316 0.7×	217 0.8×	166 1.4×	131 1.2×	156 1.8×	86	958
Jonathan Bouchard United States	20	890 1.9×	217 0.8×	99 0.8×	170 1.6×	122 1.4×	56	1.5k
Ie Byung Park South Korea	18	373 0.8×	149 0.5×	76 0.6×	199 1.9×	111 1.3×	62	829
Ho-Chun Choi South Korea	19	359 0.8×	243 0.8×	142 1.2×	104 1.0×	176 2.0×	63	1.1k
Amit D. Raval United States	21	332 0.7×	363 1.3×	156 1.3×	125 1.2×	77 0.9×	80	1.3k
Tina B Hansen Denmark	10	383 0.8×	167 0.6×	243 2.0×	130 1.2×	87 1.0×	17	945
Grishma Hirode United States	9	225 0.5×	437 1.5×	119 1.0×	103 1.0×	166 1.9×	20	998

Countries citing papers authored by Αndreas Μelidonis

Since Specialization

Citations

This map shows the geographic impact of Αndreas Μelidonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Αndreas Μelidonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Αndreas Μelidonis more than expected).

Fields of papers citing papers by Αndreas Μelidonis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Αndreas Μelidonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Αndreas Μelidonis. The network helps show where Αndreas Μelidonis may publish in the future.

Co-authorship network of co-authors of Αndreas Μelidonis

This figure shows the co-authorship network connecting the top 25 collaborators of Αndreas Μelidonis. A scholar is included among the top collaborators of Αndreas Μelidonis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Αndreas Μelidonis. Αndreas Μelidonis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Papazafiropoulou, Athanasia, et al.. (2021). Aspirin in primary prevention of cardiovascular disease in diabetes. Archives of Medical Science - Atherosclerotic Diseases. 6(1). 109–114. 1 indexed citations

Koliaki, Chrysi, Anastasios Tentolouris, Ioanna Eleftheriadou, et al.. (2020). Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns. Journal of Clinical Medicine. 9(7). 2288–2288. 32 indexed citations

Papazafiropoulou, Athanasia, et al.. (2020). Effects of Glucagon-like Peptide-1 Receptor Agonists and Sodium-glucose Cotransporter 2 Inhibitors on Cardiorenal and Metabolic Outcomes in People Without Diabetes. Current Pharmaceutical Design. 27(8). 1035–1042. 12 indexed citations

Souliotis, Kyriakos, Anastasios Koutsovasilis, Erifili Hatziagelaki, et al.. (2020). Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry. BMC Endocrine Disorders. 20(1). 16–16. 10 indexed citations

Παπάνας, Νικόλαος, Moses Elisaf, Kalliopi Kotsa, et al.. (2020). Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study. Diabetes Therapy. 11(12). 2887–2908. 3 indexed citations

Papazafiropoulou, Athanasia, et al.. (2020). Diabetes and dementia – the two faces of Janus. Archives of Medical Science - Atherosclerotic Diseases. 5(1). 186–197. 4 indexed citations

Xourgia, Eleni, Athanasia Papazafiropoulou, & Αndreas Μelidonis. (2019). Antidiabetic treatment on memory and spatial learning: From the pancreas to the neuron. World Journal of Diabetes. 10(3). 169–180. 14 indexed citations

Xourgia, Eleni, et al.. (2019). Effect of 3-month α-lipoic acid treatment on sural nerve conduction velocity and amplitude in patients with diabetic neuropathy: a pilot study. Archives of Medical Science - Atherosclerotic Diseases. 4(1). 141–143. 1 indexed citations

Xourgia, Eleni, Athanasia Papazafiropoulou, & Αndreas Μelidonis. (2018). Circulating microRNAs as biomarkers for diabetic neuropathy: A novel approach. PubMed. 8(3). 18–23. 18 indexed citations

10.

Christou, Georgios A., et al.. (2017). Serum fetuin-A levels are associated with serum triglycerides before and 6 months after bariatric surgery. HORMONES. 16(3). 297–305. 10 indexed citations

11.

Liatis, Stavros, Maria Mylona, Athanasia Papazafiropoulou, et al.. (2014). Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals. Diabetes & Metabolism. 41(2). 126–131. 10 indexed citations

12.

Karageorgopoulos, Drosos E., et al.. (2014). Severe Plasmodium vivax Malaria Complicated with Acute Respiratory Distress Syndrome: A Case Associated with Focal Autochthonous Transmission in Greece. Vector-Borne and Zoonotic Diseases. 14(5). 378–381. 7 indexed citations

13.

Liatis, Stavros, et al.. (2014). Management of type 2 diabetes and its prescription drug cost before and during the economic crisis in Greece: an observational study. BMC Endocrine Disorders. 14(1). 23–23. 11 indexed citations

14.

Μelidonis, Αndreas, et al.. (2014). Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes On Oral Antidiabetic Drugs In Greece. Value in Health. 17(7). A345–A345.

15.

Μelidonis, Αndreas, et al.. (2014). Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece. BMC Health Services Research. 14(1). 419–419. 22 indexed citations

16.

Angelidi, Angeliki M., et al.. (2013). Acute Steatohepatitis, Due to Extreme Metabolic Dysregulation, as the First Presentation of Non-Alcoholic Fatty Liver Disease. SHILAP Revista de lepidopterología. 3(2). e17–e17. 1 indexed citations

17.

Tentolouris, Nikolaοs, et al.. (2010). Heart rate variability in advanced chronic kidney disease with or without diabetes: midterm effects of the initiation of chronic haemodialysis therapy. Nephrology Dialysis Transplantation. 25(11). 3749–3754. 35 indexed citations

18.

Μelidonis, Αndreas, Evdokia N. Adamopoulou, Elias Skopelitis, et al.. (2009). Impact of the metabolic syndrome and its components combinations on arterial stiffness in Type 2 diabetic men.. PubMed. 28(6). 490–5. 12 indexed citations

19.

Kokkoris, Stelios, et al.. (2008). Prediction of long-term functional outcome in patients with acute ischemic non-embolic stroke. Atherosclerosis. 203(1). 228–235. 33 indexed citations

20.

Kokkoris, Stelios, et al.. (2007). Correlation between Increased Serum sFas Levels and Microalbuminuria in Type 1 Diabetic Patients. Medical Principles and Practice. 16(3). 222–225. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact